The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib

Abstract Cytokeratin 19-positive (CK19+) hepatocellular carcinoma (HCC) is an aggressive subtype characterized by early recurrence and chemotherapy tolerance. However, there is no specific therapeutic option for CK19+ HCC. The correlation between tumor recurrence and expression status of CK19 were s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jianyong Zhuo, Di Lu, Zuyuan Lin, Xinyu Yang, Modan Yang, Jianguo Wang, Yaoye Tao, Xue Wen, Huihui Li, Zhengxing Lian, Beini Cen, Siyi Dong, Xuyong Wei, Haiyang Xie, Shusen Zheng, Youqing Shen, Xiao Xu
Formato: article
Lenguaje:EN
Publicado: Nature Publishing Group 2021
Materias:
Acceso en línea:https://doaj.org/article/0c2f2212cdcf45f8b489bd9024689604
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!